Anti-Human LILRB4 Therapeutic Antibody (TRX385)
Recombinant Human monoclonal antibody expressed in CHO binding to Human LILRB4. TRX385 is a monoclonal antibody that recognizes ILT3, an inhibitory receptor expressed by dendritic cells and monocytes. These pre-clinical candidates may be developed for the treatment of cancer and viral diseases.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-493CL |
| Pricing | Inquiry |
| Host | Human |
| Target | LILRB4 |
| Species Reactivity | Human |
| Type | Antibody |
| Storage |
|